\-\ Texto\\:\\ \ \(0\)\
\-\ ocular\\ exam\\:\\ papilledema\\ \\&\\ ocular\\ pressure\\ of\\ 46\\ cmh2o\ \(0\)\
\-\ lp\\ \\(spinal\\ tap\\)\\ \\â\\€\\“\\ opening\\ pressure\\ of\\ 20\\.5\\ cmh2o\ \(0\)\
\-\ r\\ transverse\\ sinus\\ pressure\\ gradient\\ 13\\ mmhg\\ \\(normal\\ \\<4mmhg\\)\ \(0\)\
\-\ in\\ this\\ patient\\ had\\ stenosis\\ of\\ her\\ right\\ transverse\\ with\\ a\\ pressure\\ gradient\\ of\\ 13mm\\ hg\\ across\\ the\\ lesion\\.\\ \\ right\\ and\\ left\\ cerebral\\ angiography\\ followed\\ by\\ venogram\\ was\\ performed\\ to\\ better\\ identify\\ the\\ location\\ of\\ the\\ right\\ transverse\\ stenosis\\ and\\ surrounding\\ vessels\\ in\\ preparation\\ for\\ stenting\\.\\ \\ after\\ seeing\\ the\\ patient\\ several\\ times\\ before\\ in\\ clinic\\ for\\ an\\ adequate\\ pre\\-operation\\ work\\-up\\ she\\ was\\ scheduled\\ for\\ right\\ transverse\\ sinus\\ stenosis\\.\\ \\ access\\ was\\ obtained\\ from\\ the\\ left\\ common\\ femoral\\ vein\\ and\\ \\ angioplasty\\ of\\ the\\ right\\ transverse\\ sinus\\ was\\ performed\\ and\\ a\\ zilver\\ 7\\ x\\ 60\\ mm\\ stent\\ was\\ placed\\.\\ \\ status\\ post\\ surgery\\ the\\ patient\\ had\\ improved\\ symptoms\\ to\\ include\\ improved\\ vision\\ and\\ significant\\ decrease\\ in\\ pain\\ from\\ headaches\\.\\ \\ hope\\ to\\ continue\\ with\\ close\\ follow\\-up\\ with\\ patient\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mr\\ venogram\\ \\(mrv\\)\\ showing\\ right\\ transverse\\ sinus\\ stenosis\\,\\ proximal\\ to\\ the\\ sigmoid\\ sinus\\ and\\ interntal\\ jugular\\ vein\\ \\(ijv\\)\\ junction\\.\ \(0\)\
\-\ \\â\\€\\¢\\ cerebral\\ catheter\\ arteriogram\\ \\&\\ venography\\ demonstrate\\ a\\ high\\-grade\\ right\\ transverse\\-sigmoid\\ sinus\\ stenosis\\,\\ distal\\ to\\ the\\ vein\\ of\\ labbe\\ connection\\.\\ \\ \\ the\\ stenosis\\ was\\ estimated\\ as\\ at\\ least\\ 80\\%\\ narrowing\\,\\ to\\ an\\ approximate\\ diameter\\ of\\ 1mm\\ with\\ a\\ pressure\\ gradient\\ across\\ the\\ stenosis\\ of\\ 13\\ mmhg\\.\ \(0\)\
\-\ \\â\\€\\¢\\ neurointerventional\\ radiology\\ endovascular\\ procedure\\ was\\ successful\\ with\\ a\\ balloon\\ angioplasty\\ and\\ stent\\ placement\\ across\\ the\\ stenosis\\ in\\ the\\ right\\ transverse\\ sinus\\.\ \(0\)\
\-\ pseudotumor\\ cerebri\\ w\\/\\ right\\ transverse\\ sinus\\ stenosis\ \(0\)\
\-\ \\â\\€\\¢\\ obstruction\\ of\\ venous\\ outflow\\,\\ eg\\,\\ venous\\ sinus\\ \\ stenosis\\/thrombosis\\,\\ jugular\\ vein\\ compression\ \(0\)\
\-\ \\â\\€\\¢\\ pseudotumor\\ cerebri\\ \\(idiopathic\\ intracranial\\ hypertension\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ decreased\\ csf\\ absorption\\ \\(i\\.e\\.\\ arachnoid\\ granulation\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ increased\\ cerebrospinal\\ fluid\\ \\(csf\\)\\ production\\ \\ \\(i\\.e\\.\\ choroid\\ plexus\\ papilloma\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ intracranial\\ mass\\ lesions\\ \\(tumor\\,\\ abscess\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ obstructive\\ hydrocephalus\ \(0\)\
\-\ 26\\ y\\.o\\.\\ obese\\ woman\\ with\\ a\\ hx\\ of\\ persistent\\ and\\ disabling\\ \\(8\\/10\\)\\ \\ global\\ headache\\ and\\ a\\ recent\\ onset\\ of\\ blurred\\ vision\ \(0\)\
\-\ pseudotumor\\ cerebri\\ also\\ known\\ as\\ idiopathic\\ intracranial\\ hypertension\\ \\(iih\\)\\ is\\ defined\\ by\\ a\\ class\\ clinical\\ symptoms\\ that\\ occur\\ in\\ the\\ setting\\ of\\ elevated\\ intracranial\\ pressure\\ and\\ normal\\ composition\\ of\\ cerebrospinal\\ fluid\\.\\ \\ classic\\ clinical\\ symptoms\\ include\\ headaches\\,\\ vision\\ changes\\ \\(including\\ vision\\ loss\\)\\,\\ hearing\\ changes\\ \\(tinnitus\\)\\,\\ and\\ the\\ disease\\ is\\ typically\\ seen\\ in\\ obese\\ females\\ of\\ childbearing\\ age\\.\\ \\ papilledema\\ is\\ the\\ most\\ common\\ physical\\ exam\\ finding\\,\\ but\\ visual\\ field\\ loss\\ and\\ sixth\\ nerve\\ palsy\\ may\\ also\\ be\\ seen\\ as\\ well\\.\\ \\ symptoms\\ may\\ become\\ severe\\ to\\ include\\ severe\\ disabling\\ headaches\\ and\\ complete\\ vision\\ loss\\.\\ \\ brain\\ computed\\ tomography\\ \\(ct\\)\\ and\\ magnetic\\ resonance\\ imaging\\ \\(mri\\)\\ are\\ typically\\ normal\\,\\ however\\,\\ the\\ following\\ findings\\ may\\ be\\ seen\\,\\ but\\ are\\ currently\\ not\\ diagnostic\\:\\ \\ \ \(0\)\
\-\ \\â\\€\\“\\ cerebral\\ venous\\ sinus\\ stenosis\ \(0\)\
\-\ \\â\\€\\“\\ flattening\\ of\\ the\\ posterior\\ sclera\\ \ \(0\)\
\-\ \\â\\€\\“\\ contrast\\ enhancement\\ of\\ the\\ prelaminar\\ optic\\ nerve\\ \\ \ \(0\)\
\-\ \\â\\€\\“\\ empty\\ sella\\ \ \(0\)\
\-\ \\â\\€\\“\\ distension\\ of\\ perioptic\\ subarachnoid\\ space\\ \\ \ \(0\)\
\-\ \\â\\€\\“\\ intraocular\\ protrusion\\ of\\ the\\ prelaminar\\ optic\\ nerve\\ \\ \ \(0\)\
\-\ \\â\\€\\“\\ orbital\\ optic\\ nerve\\ vertical\\ tortuosity\\ \\ \ \(0\)\
\-\ treatment\\ for\\ pseudotumor\\ cerebri\\ typically\\ includes\\ medical\\ management\\ with\\ acetazolamide\\ and\\ pain\\ control\\ for\\ headaches\\.\\ \\ furosemide\\ \\(lasix\\Â\\®\\)\\ and\\ corticosteroids\\ can\\ be\\ used\\ as\\ well\\.\\ \\ surgical\\ interventions\\ \\ include\\ lumbo\\-peritoneal\\ shunt\\ \\(lps\\)\\ and\\ ventriculo\\-peritoneal\\ shunt\\ \\(vps\\)\\,\\ which\\ often\\ produce\\ immediate\\ results\\.\\ \\ however\\,\\ about\\ 50\\%\\ there\\ is\\ a\\ regression\\ back\\ to\\ pseudotumor\\ symptoms\\,\\ more\\ often\\ with\\ lps\\ than\\ vps\\.\\ \ \(0\)\
\-\ optic\\ nerve\\ sheath\\ fenestration\\ is\\ also\\ sometimes\\ used\\ to\\ treat\\ visual\\ changes\\ or\\ loss\\ of\\ vision\\.\\ \\ venous\\ stenting\\ of\\ the\\ stenosis\\ of\\ the\\ cerebral\\ sinuses\\ is\\ a\\ relatively\\ new\\ way\\ of\\ treating\\ pseudotumor\\.\\ \\ current\\ articles\\ show\\ mixed\\ results\\,\\ but\\ some\\ studies\\ show\\ that\\ patients\\ with\\ pseudotumor\\ may\\ have\\ some\\ cerebral\\ sinus\\ stenosis\\ approximately\\ 30\\ \\â\\€\\“\\ 90\\%\\ of\\ the\\ time\\.\\ \\ whether\\ the\\ stenosis\\ is\\ a\\ primary\\ or\\ secondary\\ cause\\ is\\ unknown\\.\\ \\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ friedman\\,\\ di\\,\\ jacobson\\,\\ dm\\.\\ \\â\\€\\œdiagnostic\\ criteria\\ for\\ idiopathic\\ intracranial\\ hypertension\\.\\â\\€\\\\ neurology\\ 2002\\;\\ 59\\:1492\\.\\ \ \(0\)\
\-\ mccarthy\\,\\ kd\\,\\ viernstein\\,\\ l\\.\\ \\â\\€\\œlong\\-term\\ intracranial\\ pressure\\ recording\\ in\\ the\\ management\\ of\\ pseudotumor\\ cerebri\\.\\â\\€\\\\ j\\ pharmacol\\ exp\\ ther\\ 1974\\;\\ 189\\:194\\.\\ \ \(0\)\
\-\ corbett\\,\\ jj\\,\\ thompson\\,\\ hs\\.\\ \\â\\€\\œthe\\ rational\\ management\\ of\\ idiopathic\\ intracranial\\ hypertension\\.\\â\\€\\\\ arch\\ neurol\\ 1989\\;\\ 46\\:1049\\.\\ \ \(0\)\
\-\ donnet\\,\\ a\\,\\ metellus\\,\\ p\\,\\ levrier\\,\\ o\\,\\ et\\ al\\.\\ \\â\\€\\œendovascular\\ treatment\\ of\\ idiopathic\\ intracranial\\ hypertension\\:\\ clinical\\ and\\ radiologic\\ outcome\\ of\\ 10\\ consecutive\\ patients\\.\\â\\€\\\\ neurology\\ 2008\\;\\ 70\\:641\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stenosis\\:\\ 0\\.32092643514967206\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.25035786902620427\ \(0\)\
\-\ sinus\\:\\ 0\\.23953073766650954\ \(0\)\
\-\ transverse\\:\\ 0\\.20896900554441972\ \(0\)\
\-\ intracranial\\:\\ 0\\.19398251167674513\ \(0\)\
\-\ cerebri\\:\\ 0\\.17424895818420696\ \(0\)\
\-\ of\\:\\ 0\\.16512533602505883\ \(0\)\
\-\ pressure\\:\\ 0\\.160618269710948\ \(0\)\
\-\ vision\\:\\ 0\\.15659826062879567\ \(0\)\
\-\ the\\:\\ 0\\.15633988951464833\ \(0\)\
\-\ idiopathic\\:\\ 0\\.12745470320122398\ \(0\)\
\-\ hypertension\\:\\ 0\\.11528816762048281\ \(0\)\
\-\ and\\:\\ 0\\.11208741781255269\ \(0\)\
\-\ nerve\\:\\ 0\\.10749162716469066\ \(0\)\
\-\ cerebral\\:\\ 0\\.10438986085774303\ \(0\)\
\-\ optic\\:\\ 0\\.10376326287977035\ \(0\)\
\-\ prelaminar\\:\\ 0\\.09638562410302043\ \(0\)\
\-\ lps\\:\\ 0\\.09638562410302043\ \(0\)\
\-\ vps\\:\\ 0\\.09638562410302043\ \(0\)\
\-\ gradient\\:\\ 0\\.0948854929785107\ \(0\)\
\-\ cmh2o\\:\\ 0\\.09210160948639494\ \(0\)\
\-\ right\\:\\ 0\\.08991971565849569\ \(0\)\
\-\ headaches\\:\\ 0\\.08991362462420047\ \(0\)\
\-\ across\\:\\ 0\\.08800662538541709\ \(0\)\
\-\ vein\\:\\ 0\\.08640230856791958\ \(0\)\
\-\ venous\\:\\ 0\\.0860609221419792\ \(0\)\
\-\ symptoms\\:\\ 0\\.08244148615999934\ \(0\)\
\-\ disabling\\:\\ 0\\.08049402351033345\ \(0\)\
\-\ cerebrospinal\\:\\ 0\\.07582576000006777\ \(0\)\
\-\ was\\:\\ 0\\.07351701076816033\ \(0\)\
\-\ loss\\:\\ 0\\.07343797491051567\ \(0\)\
\-\ venogram\\:\\ 0\\.07317045215089749\ \(0\)\
\-\ include\\:\\ 0\\.07172077794859669\ \(0\)\
\-\ stenting\\:\\ 0\\.068886437534272\ \(0\)\
\-\ angioplasty\\:\\ 0\\.06813142498185586\ \(0\)\
\-\ to\\:\\ 0\\.06780376123049023\ \(0\)\
\-\ management\\:\\ 0\\.06677850033075644\ \(0\)\
\-\ endovascular\\:\\ 0\\.0667662151642156\ \(0\)\
\-\ papilledema\\:\\ 0\\.06645079830608068\ \(0\)\
\-\ is\\:\\ 0\\.06602192558214279\ \(0\)\
\-\ mmhg\\:\\ 0\\.06527562382860493\ \(0\)\
\-\ neurology\\:\\ 0\\.06372665842140514\ \(0\)\
\-\ typically\\:\\ 0\\.06346580823016953\ \(0\)\
\-\ obese\\:\\ 0\\.062376011914246805\ \(0\)\
\-\ jugular\\:\\ 0\\.06216678368945517\ \(0\)\
\-\ ocular\\:\\ 0\\.06176036127228989\ \(0\)\
\-\ stent\\:\\ 0\\.06080785362241989\ \(0\)\
\-\ may\\:\\ 0\\.060660015541968856\ \(0\)\
\-\ in\\:\\ 0\\.059973361118346814\ \(0\)\
\-\ clinical\\:\\ 0\\.05729489877737415\ \(0\)\
\-\ shunt\\:\\ 0\\.05714920968531067\ \(0\)\
\-\ sigmoid\\:\\ 0\\.05581919927862226\ \(0\)\
\-\ 46\\:\\ 0\\.05537426279664111\ \(0\)\
\-\ for\\:\\ 0\\.05480256301297142\ \(0\)\
\-\ changes\\:\\ 0\\.05463745042516584\ \(0\)\
\-\ improved\\:\\ 0\\.053484282262983913\ \(0\)\
\-\ with\\:\\ 0\\.053107713763067124\ \(0\)\
\-\ visual\\:\\ 0\\.05142218165880625\ \(0\)\
\-\ as\\:\\ 0\\.04842558452072939\ \(0\)\
\-\ 4mmhg\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ zilver\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ interntal\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ labbe\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ perioptic\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ friedman\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ mccarthy\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ viernstein\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ corbett\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ donnet\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ metellus\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ levrier\\:\\ 0\\.048192812051510214\ \(0\)\
\-\ csf\\:\\ 0\\.04762373718287168\ \(0\)\
\-\ results\\:\\ 0\\.04696475222181645\ \(0\)\
\-\ iih\\:\\ 0\\.04605080474319747\ \(0\)\
\-\ diagnostic\\:\\ 0\\.04593542134288124\ \(0\)\
\-\ 13\\:\\ 0\\.04545607117637582\ \(0\)\
\-\ used\\:\\ 0\\.045120624586968645\ \(0\)\
\-\ but\\:\\ 0\\.044705772437367244\ \(0\)\
\-\ ijv\\:\\ 0\\.04453102637179223\ \(0\)\
\-\ acetazolamide\\:\\ 0\\.04453102637179223\ \(0\)\
\-\ recording\\:\\ 0\\.04453102637179223\ \(0\)\
\-\ pharmacol\\:\\ 0\\.04453102637179223\ \(0\)\
\-\ 1974\\:\\ 0\\.04453102637179223\ \(0\)\
\-\ thompson\\:\\ 0\\.04453102637179223\ \(0\)\
\-\ hs\\:\\ 0\\.04453102637179223\ \(0\)\
\-\ rational\\:\\ 0\\.04453102637179223\ \(0\)\
\-\ neurointerventional\\:\\ 0\\.0433521946840348\ \(0\)\
\-\ di\\:\\ 0\\.0433521946840348\ \(0\)\
\-\ jacobson\\:\\ 0\\.0433521946840348\ \(0\)\
\-\ exp\\:\\ 0\\.0433521946840348\ \(0\)\
\-\ seen\\:\\ 0\\.042562283478540866\ \(0\)\
\-\ also\\:\\ 0\\.04252426222050649\ \(0\)\
\-\ consecutive\\:\\ 0\\.042389019063479486\ \(0\)\
\-\ fenestration\\:\\ 0\\.04157466567975187\ \(0\)\
\-\ kd\\:\\ 0\\.04157466567975187\ \(0\)\
\-\ 13mm\\:\\ 0\\.040869240692074246\ \(0\)\
\-\ composition\\:\\ 0\\.040869240692074246\ \(0\)\
\-\ childbearing\\:\\ 0\\.040869240692074246\ \(0\)\
\-\ jj\\:\\ 0\\.040869240692074246\ \(0\)\
\-\ hope\\:\\ 0\\.04024701175516673\ \(0\)\
\-\ venography\\:\\ 0\\.04024701175516673\ \(0\)\
\-\ neurol\\:\\ 0\\.04024701175516673\ \(0\)\
\-\ furosemide\\:\\ 0\\.039690409004316814\ \(0\)\
\-\ ther\\:\\ 0\\.039690409004316814\ \(0\)\
\-\ often\\:\\ 0\\.039326486715698473\ \(0\)\
\-\ patient\\:\\ 0\\.039205925297682055\ \(0\)\
\-\ 1mm\\:\\ 0\\.03918690057013854\ \(0\)\
\-\ intraocular\\:\\ 0\\.03918690057013854\ \(0\)\
\-\ preparation\\:\\ 0\\.038727233383761495\ \(0\)\
\-\ seeing\\:\\ 0\\.038727233383761495\ \(0\)\
\-\ arteriogram\\:\\ 0\\.038727233383761495\ \(0\)\
\-\ approximate\\:\\ 0\\.03830438056267949\ \(0\)\
\-\ absorption\\:\\ 0\\.03830438056267949\ \(0\)\
\-\ tortuosity\\:\\ 0\\.03830438056267949\ \(0\)\
\-\ show\\:\\ 0\\.03826108980272827\ \(0\)\
\-\ severe\\:\\ 0\\.03815382309376731\ \(0\)\
\-\ some\\:\\ 0\\.03792160099682781\ \(0\)\
\-\ granulation\\:\\ 0\\.037912880000033886\ \(0\)\
\-\ 1989\\:\\ 0\\.037912880000033886\ \(0\)\
\-\ tap\\:\\ 0\\.03720745501235626\ \(0\)\
\-\ normal\\:\\ 0\\.03691205144889782\ \(0\)\
\-\ be\\:\\ 0\\.03667398853416389\ \(0\)\
\-\ lp\\:\\ 0\\.036299597594020454\ \(0\)\
\-\ hg\\:\\ 0\\.03602862332459883\ \(0\)\
\-\ sclera\\:\\ 0\\.03602862332459883\ \(0\)\
\-\ however\\:\\ 0\\.035673079506440296\ \(0\)\
\-\ performed\\:\\ 0\\.03565621488980009\ \(0\)\
\-\ tinnitus\\:\\ 0\\.03552511489042055\ \(0\)\
\-\ blurred\\:\\ 0\\.03529028333922156\ \(0\)\
\-\ 10\\:\\ 0\\.03524311770497698\ \(0\)\
\-\ mrv\\:\\ 0\\.03506544770404351\ \(0\)\
\-\ outflow\\:\\ 0\\.03506544770404351\ \(0\)\
\-\ class\\:\\ 0\\.03506544770404351\ \(0\)\
\-\ interventions\\:\\ 0\\.03506544770404351\ \(0\)\
\-\ global\\:\\ 0\\.03484979163684139\ \(0\)\
\-\ sixth\\:\\ 0\\.03484979163684139\ \(0\)\
\-\ fluid\\:\\ 0\\.03479884949282191\ \(0\)\
\-\ empty\\:\\ 0\\.034443218767136\ \(0\)\
\-\ regression\\:\\ 0\\.034251094320315895\ \(0\)\
\-\ articles\\:\\ 0\\.034251094320315895\ \(0\)\
\-\ common\\:\\ 0\\.03418026760377119\ \(0\)\
\-\ patients\\:\\ 0\\.03390544318236015\ \(0\)\
\-\ access\\:\\ 0\\.03371339262734187\ \(0\)\
\-\ dm\\:\\ 0\\.03371339262734187\ \(0\)\
\-\ treating\\:\\ 0\\.03307226263255846\ \(0\)\
\-\ opening\\:\\ 0\\.03292344039573076\ \(0\)\
\-\ connection\\:\\ 0\\.03277869599780945\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.03263781191430246\ \(0\)\
\-\ production\\:\\ 0\\.03236683764488084\ \(0\)\
\-\ identify\\:\\ 0\\.03210908701200314\ \(0\)\
\-\ eg\\:\\ 0\\.03210908701200314\ \(0\)\
\-\ outcome\\:\\ 0\\.03210908701200314\ \(0\)\
\-\ resonance\\:\\ 0\\.03162849765950357\ \(0\)\
\-\ vertical\\:\\ 0\\.03162849765950357\ \(0\)\
\-\ balloon\\:\\ 0\\.03151488381743386\ \(0\)\
\-\ way\\:\\ 0\\.03151488381743386\ \(0\)\
\-\ estimated\\:\\ 0\\.031294733628275534\ \(0\)\
\-\ distension\\:\\ 0\\.031294733628275534\ \(0\)\
\-\ sella\\:\\ 0\\.031188005957123403\ \(0\)\
\-\ magnetic\\:\\ 0\\.031083391844727585\ \(0\)\
\-\ protrusion\\:\\ 0\\.031083391844727585\ \(0\)\
\-\ 2008\\:\\ 0\\.030781433087418007\ \(0\)\
\-\ treat\\:\\ 0\\.030495804605989718\ \(0\)\
\-\ exam\\:\\ 0\\.030340191559803543\ \(0\)\
\-\ females\\:\\ 0\\.030313619654182472\ \(0\)\
\-\ produce\\:\\ 0\\.030224830336568087\ \(0\)\
\-\ palsy\\:\\ 0\\.030137508678371658\ \(0\)\
\-\ had\\:\\ 0\\.030028970881155442\ \(0\)\
\-\ sheath\\:\\ 0\\.02996707970369039\ \(0\)\
\-\ criteria\\:\\ 0\\.02988388365292029\ \(0\)\
\-\ flattening\\:\\ 0\\.029721321902389814\ \(0\)\
\-\ continue\\:\\ 0\\.029563613473322353\ \(0\)\
\-\ whether\\:\\ 0\\.029486490351190817\ \(0\)\
\-\ adequate\\:\\ 0\\.02933554179513903\ \(0\)\
\-\ successful\\:\\ 0\\.029261654716012775\ \(0\)\
\-\ tomography\\:\\ 0\\.029188786801554657\ \(0\)\
\-\ well\\:\\ 0\\.029183265238991438\ \(0\)\
\-\ computed\\:\\ 0\\.02904599864881065\ \(0\)\
\-\ immediate\\:\\ 0\\.028838801894930773\ \(0\)\
\-\ 2002\\:\\ 0\\.028838801894930773\ \(0\)\
\-\ treatment\\:\\ 0\\.028710029364274952\ \(0\)\
\-\ better\\:\\ 0\\.02844730133228516\ \(0\)\
\-\ sinuses\\:\\ 0\\.028384781785564916\ \(0\)\
\-\ field\\:\\ 0\\.028322993478383646\ \(0\)\
\-\ choroid\\:\\ 0\\.028261919502897196\ \(0\)\
\-\ sometimes\\:\\ 0\\.028201543530984582\ \(0\)\
\-\ radiologic\\:\\ 0\\.02808282302825534\ \(0\)\
\-\ obstructive\\:\\ 0\\.028024448511203157\ \(0\)\
\-\ setting\\:\\ 0\\.028024448511203157\ \(0\)\
\-\ scheduled\\:\\ 0\\.027966711979785584\ \(0\)\
\-\ angiography\\:\\ 0\\.027853098137715873\ \(0\)\
\-\ least\\:\\ 0\\.027853098137715873\ \(0\)\
\-\ papilloma\\:\\ 0\\.027632947948557546\ \(0\)\
\-\ arachnoid\\:\\ 0\\.02752622027740542\ \(0\)\
\-\ hx\\:\\ 0\\.027421606165009597\ \(0\)\
\-\ hearing\\:\\ 0\\.027370065853361936\ \(0\)\
\-\ close\\:\\ 0\\.027268469644527723\ \(0\)\
\-\ plexus\\:\\ 0\\.02716879046013292\ \(0\)\
\-\ times\\:\\ 0\\.027119647407700023\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.027119647407700023\ \(0\)\
\-\ catheter\\:\\ 0\\.026787880292028148\ \(0\)\
\-\ become\\:\\ 0\\.026742141131491957\ \(0\)\
\-\ orbital\\:\\ 0\\.02643259753434258\ \(0\)\
\-\ current\\:\\ 0\\.026389821267905893\ \(0\)\
\-\ that\\:\\ 0\\.026155129619422426\ \(0\)\
\-\ showing\\:\\ 0\\.026019665542544115\ \(0\)\
\-\ decrease\\:\\ 0\\.025901827793604365\ \(0\)\
\-\ control\\:\\ 0\\.025748691273122487\ \(0\)\
\-\ by\\:\\ 0\\.02559434284219854\ \(0\)\
\-\ arch\\:\\ 0\\.02556330944373452\ \(0\)\
\-\ clinic\\:\\ 0\\.025384212969092664\ \(0\)\
\-\ mixed\\:\\ 0\\.024945130211924463\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.024600133823179205\ \(0\)\
\-\ relatively\\:\\ 0\\.024539757851266594\ \(0\)\
\-\ 26\\:\\ 0\\.02448006410832644\ \(0\)\
\-\ before\\:\\ 0\\.02436266283148517\ \(0\)\
\-\ diameter\\:\\ 0\\.024219487671668656\ \(0\)\
\-\ junction\\:\\ 0\\.024135408867109062\ \(0\)\
\-\ radiology\\:\\ 0\\.024135408867109062\ \(0\)\
\-\ 90\\:\\ 0\\.02408009066488955\ \(0\)\
\-\ procedure\\:\\ 0\\.024025345718602566\ \(0\)\
\-\ references\\:\\ 0\\.024025345718602566\ \(0\)\
\-\ al\\:\\ 0\\.02394427752867443\ \(0\)\
\-\ from\\:\\ 0\\.023936880859019044\ \(0\)\
\-\ et\\:\\ 0\\.02360668396480974\ \(0\)\
\-\ placement\\:\\ 0\\.02353174880710829\ \(0\)\
\-\ 80\\:\\ 0\\.02350700478041494\ \(0\)\
\-\ placed\\:\\ 0\\.023482376110908226\ \(0\)\
\-\ includes\\:\\ 0\\.02343346057586553\ \(0\)\
\-\ vessels\\:\\ 0\\.023384993813523925\ \(0\)\
\-\ narrowing\\:\\ 0\\.023360926163509158\ \(0\)\
\-\ persistent\\:\\ 0\\.023218778393824413\ \(0\)\
\-\ currently\\:\\ 0\\.02314911355958383\ \(0\)\
\-\ an\\:\\ 0\\.023047230593816446\ \(0\)\
\-\ are\\:\\ 0\\.022869907418157608\ \(0\)\
\-\ unknown\\:\\ 0\\.02283563279107452\ \(0\)\
\-\ about\\:\\ 0\\.022560312293484323\ \(0\)\
\-\ 60\\:\\ 0\\.022539716399791306\ \(0\)\
\-\ classic\\:\\ 0\\.022539716399791306\ \(0\)\
\-\ femoral\\:\\ 0\\.022397750542953843\ \(0\)\
\-\ occur\\:\\ 0\\.022162918991754845\ \(0\)\
\-\ studies\\:\\ 0\\.02210580665128039\ \(0\)\
\-\ compression\\:\\ 0\\.022068071919122148\ \(0\)\
\-\ pain\\:\\ 0\\.02156699704358441\ \(0\)\
\-\ mm\\:\\ 0\\.021566272865331197\ \(0\)\
\-\ including\\:\\ 0\\.021566272865331197\ \(0\)\
\-\ defined\\:\\ 0\\.021498325432938132\ \(0\)\
\-\ spinal\\:\\ 0\\.021398015329838267\ \(0\)\
\-\ obtained\\:\\ 0\\.021315854419669284\ \(0\)\
\-\ complete\\:\\ 0\\.021123729972849187\ \(0\)\
\-\ obstruction\\:\\ 0\\.021108030585244904\ \(0\)\
\-\ 50\\:\\ 0\\.021045695466252196\ \(0\)\
\-\ status\\:\\ 0\\.02103022593824099\ \(0\)\
\-\ location\\:\\ 0\\.02098408730399741\ \(0\)\
\-\ or\\:\\ 0\\.020967028024393788\ \(0\)\
\-\ new\\:\\ 0\\.020848040986433745\ \(0\)\
\-\ headache\\:\\ 0\\.020773946643637933\ \(0\)\
\-\ left\\:\\ 0\\.02055957643499274\ \(0\)\
\-\ 30\\:\\ 0\\.02055770199195067\ \(0\)\
\-\ elevated\\:\\ 0\\.020543595601617243\ \(0\)\
\-\ cause\\:\\ 0\\.0205295267782799\ \(0\)\
\-\ recent\\:\\ 0\\.020404565471468794\ \(0\)\
\-\ followed\\:\\ 0\\.020349961987513373\ \(0\)\
\-\ surrounding\\:\\ 0\\.020098034805573626\ \(0\)\
\-\ back\\:\\ 0\\.020098034805573626\ \(0\)\
\-\ space\\:\\ 0\\.02005933250763379\ \(0\)\
\-\ finding\\:\\ 0\\.019808319020234732\ \(0\)\
\-\ several\\:\\ 0\\.01977167489614754\ \(0\)\
\-\ known\\:\\ 0\\.019510447566835756\ \(0\)\
\-\ mr\\:\\ 0\\.01949887507580954\ \(0\)\
\-\ abscess\\:\\ 0\\.01935069509052247\ \(0\)\
\-\ onset\\:\\ 0\\.01935069509052247\ \(0\)\
\-\ approximately\\:\\ 0\\.01922847882926074\ \(0\)\
\-\ medical\\:\\ 0\\.019152151639217695\ \(0\)\
\-\ age\\:\\ 0\\.01891920311781619\ \(0\)\
\-\ her\\:\\ 0\\.0188267895652102\ \(0\)\
\-\ proximal\\:\\ 0\\.0188267895652102\ \(0\)\
\-\ brain\\:\\ 0\\.01878623013341932\ \(0\)\
\-\ decreased\\:\\ 0\\.018666387412939512\ \(0\)\
\-\ primary\\:\\ 0\\.01852992270231018\ \(0\)\
\-\ following\\:\\ 0\\.01807828049095486\ \(0\)\
\-\ she\\:\\ 0\\.017938791462261912\ \(0\)\
\-\ time\\:\\ 0\\.017861917736568093\ \(0\)\
\-\ secondary\\:\\ 0\\.017861917736568093\ \(0\)\
\-\ distal\\:\\ 0\\.017509324342029994\ \(0\)\
\-\ significant\\:\\ 0\\.017399424746410954\ \(0\)\
\-\ enhancement\\:\\ 0\\.01734532057155309\ \(0\)\
\-\ lesions\\:\\ 0\\.017307011193804966\ \(0\)\
\-\ than\\:\\ 0\\.017082811777094715\ \(0\)\
\-\ more\\:\\ 0\\.01654747091896398\ \(0\)\
\-\ post\\:\\ 0\\.0163975468279158\ \(0\)\
\-\ physical\\:\\ 0\\.01634001987063456\ \(0\)\
\-\ increased\\:\\ 0\\.016295705793794635\ \(0\)\
\-\ surgery\\:\\ 0\\.01620198056714835\ \(0\)\
\-\ imaging\\:\\ 0\\.015837089396091554\ \(0\)\
\-\ can\\:\\ 0\\.015814020188948123\ \(0\)\
\-\ tumor\\:\\ 0\\.015762479877300457\ \(0\)\
\-\ woman\\:\\ 0\\.0156945324449074\ \(0\)\
\-\ most\\:\\ 0\\.01568329235547367\ \(0\)\
\-\ demonstrate\\:\\ 0\\.015666476935310526\ \(0\)\
\-\ posterior\\:\\ 0\\.015583193444188185\ \(0\)\
\-\ mri\\:\\ 0\\.01546875922164615\ \(0\)\
\-\ have\\:\\ 0\\.015054206229515567\ \(0\)\
\-\ findings\\:\\ 0\\.014872950544602598\ \(0\)\
\-\ surgical\\:\\ 0\\.01464671051239042\ \(0\)\
\-\ contrast\\:\\ 0\\.014642098691895937\ \(0\)\
\-\ after\\:\\ 0\\.014619099787304047\ \(0\)\
\-\ lesion\\:\\ 0\\.014447505282073045\ \(0\)\
\-\ which\\:\\ 0\\.013702794264390698\ \(0\)\
\-\ disease\\:\\ 0\\.01264970393233411\ \(0\)\
\-\ there\\:\\ 0\\.011990719176459035\ \(0\)\
\-\ not\\:\\ 0\\.011896676608578976\ \(0\)\
\-\ mass\\:\\ 0\\.011510857889015865\ \(0\)\
\-\ ct\\:\\ 0\\.011472769475712498\ \(0\)\
\-\ at\\:\\ 0\\.011382462318685026\ \(0\)\
\-\ this\\:\\ 0\\.010355011763441517\ \(0\)\
